CASI Pharmaceuticals: Funding, Investors & Team (Oct 2026)
CASI Pharmaceuticals, Inc. is a biopharmaceutical company in the United States that is dedicated to creating and selling new therapies and drugs in China, the U.S., and globally. The company is specifically interested in expanding its offerings in hematology oncology and other areas where there is a demand for medical treatments. CASI is working towards becoming a top player in the biopharmaceutical industry by introducing medicines in the Chinese market using its expertise in regulation and commercialization in China, as well as its knowledge in global drug development.
CASI Pharmaceuticals has raised $35.0M across 2 funding rounds on record, the most recent an undisclosed round of $20.0M announced in Dec 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CASI Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Dec 2025.
CASI Pharmaceuticals Funding Rounds
CASI Pharmaceuticals raised $15.0M in an undisclosed round announced in Jun 2024.
1.5 years later, an undisclosed round of $20.0M was announced in Dec 2025.
CASI Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
CASI Pharmaceuticals Funding Compared to Other Biotechnology Startups
CASI Pharmaceuticals' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CASI Pharmaceuticals in Biotechnology and Rockville
Companies Similar to CASI Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
CASI Pharmaceuticals Funding FAQs
What does CASI Pharmaceuticals do?
CASI Pharmaceuticals, Inc. is a biopharmaceutical company in the United States that is dedicated to creating and selling new therapies and drugs in China, the U.S., and globally. The company is specifically interested in expanding its offerings in hematology oncology and other areas where there is a demand for medical treatments. CASI is working towards becoming a top player in the biopharmaceutical industry by introducing medicines in the Chinese market using its expertise in regulation and commercialization in China, as well as its knowledge in global drug development.
How much funding has CASI Pharmaceuticals raised?
CASI Pharmaceuticals has raised $35.0M across 2 rounds on record. The most recent is an undisclosed round of $20.0M announced in Dec 2025.
When did CASI Pharmaceuticals last raise funding?
CASI Pharmaceuticals' most recent funding round on record is an undisclosed round of $20.0M, announced in Dec 2025.
Who founded CASI Pharmaceuticals?
FundedIQ lists John W Holaday (Founder) at CASI Pharmaceuticals.
Where is CASI Pharmaceuticals headquartered?
CASI Pharmaceuticals is based in Rockville, Maryland, United States.
How many employees does CASI Pharmaceuticals have?
CASI Pharmaceuticals is in the 101-250 employee band.
How does CASI Pharmaceuticals' funding compare to other Biotechnology startups?
CASI Pharmaceuticals' latest round of $20.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's CASI Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CASI Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.